SMA Solar Technology

Phase A — Understand the business

Lens 1 · Company Overview

SMA Solar Technology AG (founded 1981, HQ Niestetal near Kassel, Germany; ~3,500–3,660 employees in 2025 ) designs, manufactures and sells power-electronics for the energy transition — principally PV inverters (the box that converts DC from solar panels into grid-quality AC), battery/storage inverters, medium-voltage power stations, monitoring software and grid-services engineering. It is one of the last independent Western pure-play inverter OEMs and the #3 solar-inverter maker globally / #1 in Europe.

Since a 2025 reorganization the group reports two segments (collapsing the old three-way Home / C&I / Large-Scale split):

• Large Scale & Project Solutions (LSP) — central inverters (Sunny Central), utility-scale PV + BESS power stations, grid-forming inverters, and the SMA Altenso engineering/EPC-services unit. FY2025: €1,268.8m revenue, 83.7% of group, EBIT +€210.8m. This is the crown jewel.
• Home & Business Solutions (HBS) — residential/commercial string inverters (Sunny Boy, Sunny Tripower), home storage, EV charging. FY2025: €247.2m revenue (−30% YoY), 16.3% of group, EBIT −€375.6m. This is the value-destroyer.

Contract structure: LSP is project/backlog-driven — large lumpy orders from utility developers, IPPs and EPCs, with a reported group order backlog of €1,352m at end-2025 (product backlog €1,018m) rising to €1.41bn after Q1 2026. Revenue is recognized on delivery/commissioning, not take-or-pay recurring; SMA carries multi-year warranty obligations (10-yr limited product warranty in US/Canada ) and long-tail service revenue. HBS is channel/distribution-driven — sell-through via installers and distributors, which is exactly why it blew up in 2024 (channel inventory glut). No single end-customer dominates group revenue; concentration is by channel (LSP) and geography (see Lens 4).

Lens 2 · Supply Chain

Upstream inputs → SMA → end customer, with named stakeholders:

• Semiconductors (the critical input): power switches — SiC MOSFETs and IGBTs — from merchant power-semi vendors (Infineon, STMicroelectronics, onsemi, Wolfspeed are the industry's SiC/IGBT suppliers; SMA does not publicly single-source-disclose, so treat specific vendor attribution as n/a — not disclosed). SiC content is rising and is the technical differentiator in the newest grid-forming line (99.5% efficiency claim). Magnetics, capacitors, enclosures, PCBs round out the BOM.
• Strategic anchor supplier/partner — Danfoss A/S (Denmark): SMA bought Danfoss's solar-inverter operations in 2013; Danfoss is now the largest shareholder (~20%) and a power-electronics technology ally (Lens 9). This is both a supply-chain and a governance link.
• Manufacturing (SMA itself): Niestetal, Germany is the core plant (~21 GW existing capacity across the range; a "GIGAWATT FACTORY" expansion targets ~40 GW). Production is split Germany + China: single-phase Sunny Boy historically built in China, three-phase Sunny Tripower and the newest Sunny Boy AV in Germany; SMA reversed a 2017 China-outsourcing push and re-shored key lines from 2018–19. That German cost base is the core of the HBS margin problem.
• Downstream (LSP): utility-scale PV/BESS developers, IPPs, EPCs — heavily Americas (47.9% of LSP revenue) and EMEA (38.6%). Notable partner: HyperStrong (top-10 Chinese BESS integrator, ~6% share) — expanded 2025 cooperation for global utility-scale storage projects, giving SMA inverter attach to Chinese-integrated BESS.
• Downstream (HBS): distributors and installers across EMEA (80% of HBS revenue).

Chokepoints / single-source risk: SiC power-semiconductor availability and pricing is the genuine chokepoint (shared industry-wide). The Danfoss relationship is a concentration of both supply and governance in one strategic counterparty. Names are present — this lens passes.

Lens 3 · Competitive Advantages (moats)

SMA's moat is narrow, technology-and-trust-based, and unevenly distributed across its two segments.

• Grid-forming / grid-services technology (real, durable-ish). As grids displace synchronous coal/gas generation with inverter-based solar+wind, they lose physical inertia; grid-forming inverters synthesize voltage/frequency reference and inertia to prevent frequency collapse — something commodity "grid-following" inverters cannot do. SMA is early and credible here, paired with Power Plant Manager software and dedicated engineering services. This is the closest thing to a defensible edge and it sits in the good segment (LSP).
• Utility relationships + service/warranty install base. 40+ years, a large fielded fleet, and 10-year warranties create switching friction for utility/EPC buyers who value bankability and 20-year serviceability over lowest sticker price. Genuine but erodable.
• "Made in Germany" / non-Chinese origin. Increasingly a geopolitical moat rather than a quality one — see the US Chinese-inverter ban (Lens 8/12). It is also a cost disadvantage in commodity residential (HBS), which is why that segment can't compete with Chinese string inverters on price.
• Brand. Strong in Europe, weaker globally vs Huawei/Sungrow scale.

Bargaining power: Weak vs Chinese cost leaders — Sungrow ($42bn market cap) and Huawei out-scale SMA (€2.1bn) by an order of magnitude and set the price in commodity segments; SMA is a price-taker there. Moderate-to-strong in grid-forming/utility niches where bankability, grid-code compliance and Western supply-chain provenance matter and Chinese kit is politically constrained. Over suppliers (power-semis) SMA has little leverage; over utility customers it has some, via qualification lock-in. Net: a niche moat in LSP, effectively no moat in HBS.

Lens 4 · Segments

`` — FY2025 vs FY2024:

Geography within LSP (FY2025): Americas 47.9% · EMEA 38.6% · APAC 13.5%. Within HBS: EMEA 80.2% · Americas 14.5% · APAC 5.3%. So the good segment is US-heavy (tariff/ban-sensitive) and the bad segment is Europe-heavy (where residential demand collapsed).

Reconciliation ``: LSP +€210.8m − HBS €375.6m = −€164.8m, vs group EBIT −€188.2m ⇒ ~−€23m central/reconciliation. LSP EBIT margin 16.6% in 2025 (vs 19.3% in 2024) — the decline flagged: warranty provisions + a €7.5m US receivables impairment dented LSP, and 2026 guidance is for LSP EBIT below 2025 on higher opex and lower R&D capitalization. HBS's −€375.6m is impairment/one-off-laden (goodwill, capitalized dev, inventory writedowns), not a cash burn of that size — but it signals the segment destroyed enormous accounting value. Trend: LSP decelerating-but-solid; HBS collapsing then stabilizing. The whole equity case is "is HBS's −€375m a one-time reset or a structural sinkhole?"

---

Phase B — Measure performance

Lens 5 · Earnings Result (FY2025 final + Q1 2026)

FY2025 (reported ~26 Mar 2026) — a kitchen-sink year:

• Revenue €1,516.0m, −0.9% YoY (2024: €1,530.0m).
• Operating EBITDA before one-offs €106.6m (2024: €147.5m); operating EBIT before one-offs €54.3m (2024: €76.8m) — i.e. the underlying business stayed marginally profitable.
• Reported EBITDA −€65.4m (2024: −€16.0m) and reported EBIT −€188.2m, EBIT margin −12.4% (2024: −€93.1m / −6.1%).
• Net loss −€181.1m (2024: −€117.7m). Data-conflict resolved: several secondary outlets (PV-Tech: "losses exceed US$75m") cite €65.4m as the "loss" — that is reported EBITDA, not net income; the actual net loss is −€181.1m. Drivers: inventory writedowns/scrapping, provisions for purchase obligations, and restructuring/transformation one-time items.
• Balance sheet is the good-news story: net cash +€176.4m at end-2025 (2024: €84.2m) — cash rose despite the loss, via working-capital release (inventory run-down). No net debt.
• Order backlog held: €1,352.0m (2024: €1,355.6m).

Q1 2026 (reported ~13 May 2026):

• Revenue €340.9m, +4% YoY (Q1'25 €327.7m).
• HBS €61.4m (+27.9%), EBIT −€20m (improved from −€46m); LSP €279.5m (flat), EBIT €34m (down from €50m Q1'25).
• Operating group EBITDA before one-offs +67% YoY.
• Net loss −€1.6m (vs +€5.5m profit Q1'25) — essentially breakeven at the net line.
• Cash flow turned negative: operating CF −€22.2m (Q1'25 +€109.6m), FCF −€27m (Q1'25 +€96m); net cash fell 16% to €148m on working-capital build + restructuring cash costs.
• Order backlog rose to €1.41bn; entered Finland with a flagship storage project.
• Guidance refined to the upper third of the €1,475–1,675m sales / €50–180m EBITDA ranges.

Read: operationally inflecting (HBS loss halving, EBITDA +67%), but the cash statement is a caution — the P&L recovery is running ahead of cash conversion, and Q1 is seasonally weak. Market reaction has been strongly positive over 2026 (stock +27% in 90 days into July), so a lot of the operating improvement is already in the tape.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts/ on disk — sentiment is reconstructed from `` call coverage (GuruFocus/Yahoo/TickerReport Q1 2026; SMA IR statements FY2025). Arc over the last ~4 prints:

• Mid-2024 → late-2024: crisis/defensive. Two profit warnings (Jun & Nov 2024), CEO language about "restoring competitiveness," restructuring announced. Tone: damage control.
• FY2025 (Mar 2026): "challenging market environment and one-time items from the restructuring and transformation program" — management framing 2025 explicitly as the reset/kitchen-sink year; emphasis shifted to backlog resilience and cost-out progress (€124m of savings achieved, ~€100m more to land in earnings from 2027).
• Q1 2026 (May 2026): "cautiously optimistic." New recurring phrases: "upper third of guidance," "Large Scale demand sustained," "HBS back on a path to success," BESS/grid-forming/software as the growth narrative. Notably stopped leading with crisis language; started leading with order intake and margin recovery — but management still explicitly flags geopolitics/tariffs/FX as swing factors. Sentiment trend: crisis (2024) → reset (2025) → cautious recovery (2026), with the tell being that they now volunteer upside scenarios rather than only downside.

Lens 7 · Comps

Peer table — Western/global listed inverter & solar-power-electronics names. Multiples are `` (July 2026, mixed sources — treat as approximate) or n/a. SMA reports in EUR; peers in USD/CNY — cross-currency, so read EV/Sales and P/E directionally, not to the decimal.

Takeaways: SMA is the cheapest of the group on EV/Sales (~1.2–1.3x) — but that's a distressed-margin discount, not a bargain, because its trailing margins are negative and its return-to-profit is only just underway. On forward P/E (~30x) it is not cheap — it screens expensive for a company earning consensus €1.90–2.08 in 2026. The valuation only works if you underwrite the 2027+ cost-out + LSP/BESS growth path (Lens 11). Sungrow's $42bn vs SMA's ~€2bn is the single most important comp fact: the Chinese scale leader is ~20x SMA's size and sets commodity pricing.

Lens 8 · Stock-Price Catalysts (moves >5%, ~5yr)

Mostly ``:

• 2021–22: re-rating on the renewables boom; +~80% in 2022, a top SDAX performer. Danfoss took its ~20% strategic stake (from founder-family holders) in this window.
• Early Jul 2023: all-time high €112.70 after multiple upward guidance revisions — peak euphoria.
• Jun 2024 — Profit warning #1 (−30% in a day): 2024 EBITDA guide slashed from €220–290m to €80–130m; sales from €1.95–2.2bn to €1.55–1.7bn. Blamed high channel inventory, volatile demand, EU-parliament + US-election uncertainty.
• Nov 2024 — Profit warning #2: 2024 earnings cut to −€20m to +€20m; up to 1,100 job cuts announced. Peak-to-trough the stock fell ~90% from the 2023 high by end-2024.
• Oct 2025 — restructuring expanded: +€100m savings, +~350 more jobs cut — a negative headline the market increasingly read as positive (credible cost-out).
• Mar–Jul 2026 — recovery: FY2025 kitchen-sink + 2026 guidance, then Q1 "upper-third" refinement; sell-side PT hikes (Jefferies to €71, DB €17→€28, Berenberg €36→€41). +27% in the 90 days into July 2026 to €60.60.

What the tape actually reacts to: (1) guidance revisions (both warnings and raises move it 25–30% in a day — this is a high-beta guidance stock), (2) inventory/demand signals in residential Europe (HBS), and (3) increasingly, cost-out credibility + US policy (Chinese-inverter ban headlines). It is not a steady compounder — it trades as a boom/bust cyclical on the European residential cycle plus a policy option.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO — Dr. Jürgen Reinert. On the Managing Board since Apr 2014, CEO since Oct 2018, Chairman since Jul 2023; mandate extended to 30 Jun 2028. An engineer (power electronics), long-tenured insider, also Labor Director. Track record: mixed-to-poor on this cycle — he presided over the 2021–23 boom and the 2024 double-profit-warning that vaporized ~90% of the market cap. Bulls credit him with the decisive restructuring and the LSP/grid-forming strategic pivot; bears note the guidance credibility was destroyed on his watch (guiding €220–290m EBITDA in early 2024, delivering ~breakeven). The board's decision to extend rather than replace him signals continuity/insider confidence, but it is a red-flag-adjacent call given the miss.
• CFO — Dr. Kaveh Rouhi (since 1 May 2025). Internal promotion — Head of Finance & Controlling from Jul 2024, and a co-architect of the restructuring program since Sept 2024. Replaced Barbara Gregor, who left "prematurely, at her own request" as of 30 Apr 2025. A CFO exit mid-crisis is a governance flag, though the internal, restructuring-fluent successor mitigates it — read as managed transition, not a rupture.
• Ownership / skin in the game: Danfoss A/S ~20% (largest, strategic industrial anchor); founder-family/foundation bloc — Lars Cramer ~10%, cdw-Stiftung 8.65%, Uwe Kleinkauf 7.19%, Verena Salzmann 4.99% (founders were Werner Kleinkauf, the late Günther Cramer, Peter Drews, Reiner Wettlaufer); retail ~57%, institutions ~23%. This is a classic German Mittelstand cap table: patient founder/foundation capital + a strategic partner, minimal free-float pressure. Aligns long-term but can under-prioritize minority-shareholder returns (e.g. dividend suspended). Insider management ownership specifically is not disclosed here — n/a.
• Capital allocation: conservative. Kept net cash through the crisis; suspended the dividend (last paid May 2024) to preserve the balance sheet — the right call. Investing into the Gigawatt Factory and LSP/BESS/grid-forming. No value-destroying M&A or buybacks-at-the-top on record. The knock is forecasting/operational discipline, not balance-sheet discipline.
• Archetype: professional-manager-led, founder/foundation-owned. Implication: steady, engineering-driven, unlikely to do anything reckless — but also unlikely to move with Chinese-competitor speed/aggression.

Lens 10 · Forensic Red Flags

Ground truth on filings is thin (no EDGAR; IFRS annual report referenced via ``), so this is a framework read, labeled:

• Revenue recognition (LSP): project/percentage-of-completion-style utility revenue with long warranty tails is inherently estimate-heavy. Watch: the €7.5m US receivables impairment in LSP (2025) and rising warranty provisions — both flagged by the company itself. Not alarming at current size, but the area to monitor.
• Inventory: the entire 2024–25 crisis was an inventory event — writedowns and scrapping drove the losses. That the writedowns are now largely taken (net cash rose on inventory run-down) is reassuring; the risk is another leg down in HBS pricing forcing more.
• One-time items / "operating before one-offs": management leans hard on "before one-time items" metrics (EBIT €54.3m operating vs −€188.2m reported). That gap is €242m — legitimate (restructuring/impairment) but large enough that you must underwrite whether 2026–27 "one-offs" keep recurring. Serial "one-time" charges are the classic tell; SMA has now had two consecutive heavily-adjusted years. This is the #1 forensic watch item.
• Cash vs earnings: in Q1 2026 operating CF (−€22.2m) diverged sharply from improving operating EBITDA — working-capital + restructuring cash. Monitor full-year cash conversion; a P&L recovery that doesn't convert to cash would be a yellow flag.
• Goodwill/intangibles & capitalized R&D: HBS impairments hit these; 2026 guidance explicitly assumes lower R&D capitalization (a conservative, quality-positive move — less earnings flattered by capitalized dev).
• SBC: not a material distortion for a German industrial of this size (n/a — not quantified).

Regulatory findings (from regulatory/regulatory-findings.md + web):

• SEC (EDGAR EFTS — LR + AAER): none possible. SMA has no CIK and is not an SEC filer; total SEC findings = 0 [research scaffold: regulatory/regulatory-findings.md].
• Non-SEC enforcement (web): no material FTC/DOJ/EU/German-regulator enforcement action, fine, consent decree, product recall or accounting investigation found.
• Litigation (ordinary-course IP): SMA is plaintiff vs SolarEdge (Düsseldorf patent suit; SMA won on one of two patents in Dec 2019, under appeal) — i.e. SMA asserts its IP offensively. SMA (America) is defendant vs Tigo Energy (six patents, rapid-shutdown tech). These are normal industry IP skirmishes, not material.
• ESG note: SMA appears in the activist "Who Profits" database re: supply to Israeli-occupied-territory projects — an activist-registry flag, not a legal/regulatory finding; low materiality but worth logging.
• Verdict: No material regulatory or accounting-fraud findings. The real forensic risk is serial "one-time" adjustments, not fraud.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection (FY2026 / FY2027 / FY2028)

Built bottom-up from FY2025 actuals + 2026 guidance/consensus. All outputs ``; no forecast.ts logged (watchlist/unattended mode). 34.7m shares.

Anchors: 2026 company guidance sales €1,475–1,675m (midpoint €1,575m; refined to upper third ⇒ ~€1,540–1,675m) / EBITDA €50–180m (upper third ⇒ ~€137–180m). Consensus: revenue €1.62bn, EPS €1.90–2.08, EBITDA €139m. Cost-out: €124m achieved, ~€100m more into earnings from 2027.

Interpretation: at €60.60, base-case forward P/E is ~30x (2026) → ~22x (2027) → 18x (2028); the stock is priced for the base-to-bull path to execute. Bear case (€1.20 in 2027) implies ~50x — i.e. meaningful downside if HBS stays structurally loss-making or LSP margin compresses. The asymmetry is only attractive on a pullback or on hard evidence the 2027 cost-out + LSP margin hold.

Sum-of-parts sanity check ``: value LSP alone at 8–10x its €210.8m 2025 EBIT = €1.69–2.11bn — roughly the entire current EV (€1.95bn). So at today's price you're paying ~fair value for Large Scale and getting HBS + the €148m net cash + BESS/grid-forming/US-ban optionality as a thin residual. That's the bull's core argument — and also why there's little margin of safety if LSP EBIT (already declining) keeps sliding.

Lens 12 · Bull vs Bear

Bull case. You are buying the #1 European / #3 global inverter franchise at ~1.2x sales, net-cash, one year into a credible, quantified restructuring (€124m done, €224m total). The good segment — Large Scale & BESS + grid-forming — is growing (+7.9% in a down year), 16%+ EBIT margin, US-weighted into a market where Washington is drafting a ban on Chinese inverters (Huawei/Sungrow) — a policy gift to the only credible non-Chinese utility supplier. Grid-forming inverters + Power Plant Manager software are a genuine, rising-value niche as inverter-based grids need synthetic inertia. HBS losses are halving; if it merely reaches breakeven, group earnings inflect hard (base €2.80 → bull €4.30 EPS in 2027). Contrarian kicker: the market still frames SMA as "the busted residential-solar stock," when 84% of revenue is now a healthy utility/grid business.

Bear case (2–3 permanent-impairment risks). (1) China follows SMA up-market. Sungrow/Huawei/TBEA already dominate utility-scale globally and are moving into grid-forming and BESS — if the grid-forming niche commoditizes, SMA's only real moat erodes and LSP margins (already down 19.3%→16.6%, guided lower again) grind toward mid-single digits. (2) HBS is a structural sinkhole, not a one-off. European residential solar demand is post-subsidy, price-deflationary, and Chinese-string-inverter-dominated; SMA's German cost base may make HBS permanently uncompetitive, in which case the −€375m of "one-offs" is really the market telling you the segment is worth little. (3) The re-rating already happened. +27% in 90 days, above the €42 average PT, ~30x forward earnings — expectations are now high for a guidance-warning-prone cyclical. Pre-mortem (18 months out, thesis broke): a soft European residential recovery + a Chinese price attack on utility inverters + a stalled/blocked US inverter-ban rule ⇒ 2027 EPS lands near the bear €1.20, cash conversion stays poor, and the stock round-trips to the low-€30s. Are multiples too high? On reported trailing numbers, yes (loss-making); on 2027 base they're reasonable if execution holds. Contrarian view of what the market refuses to see: the market treats SMA as a single "solar recovery" ticker, but it is really two businesses — a fundable, arguably-cheap grid infrastructure company stapled to a melting residential ice cube; the mispricing (either way) is in how you weight the ice cube.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull:

• Revenue concentration: ~84% of revenue and ~all of the profit is one segment (LSP), and ~48% of LSP is the Americas — a single policy regime. If the US inverter-ban rule doesn't land (or if US utility solar slows under tariff cost inflation), the entire earnings story is exposed. The bull case is really a bet on US energy policy, dressed up as a company.
• The moat is thinner than bulls think: "grid-forming" is a feature, not a franchise — Sungrow demonstrated grid-forming BESS at scale, and Chinese vendors have the semiconductor supply, the cost base, and the balance sheets to out-invest SMA (~€2bn) 20:1. SMA even partners with HyperStrong (Chinese) for BESS — it is being pulled into the Chinese supply chain, not walling itself off from it.
• Most dangerous competitor bulls underestimate: Sungrow — not on price, but on up-market encroachment into exactly SMA's grid-forming/utility niche, with 20x the R&D budget.
• Capital-allocation / accounting: two straight years of enormous "one-time" charges (€242m EBIT bridge in 2025 alone), a mid-crisis CFO change, a CEO whose guidance credibility was destroyed yet whose contract was extended, and a dividend suspended — a shareholder-return-indifferent, founder/foundation-controlled cap table. None is fraud; all reduce the quality of the print you're underwriting.
• What must hold for €60.60: European residential recovers (HBS to ~breakeven by 2027), LSP margin holds ~15%+, €224m of savings sticks, and the US stays open to (or bans Chinese in favor of) SMA. That's four things, three outside management's control.
• Growth disappoints 20–30%: if 2027 revenue is €1.3bn not €1.65bn and LSP margin is 12%, group EBIT is ~€60m, net ~€40m, EPS ~€1.15 — the stock at 30x that is a low-€30s stock. ~40–50% downside on a disappointment, vs the bull's ~€90 (P/E 21x on €4.30).
• Single permanent-impairment scenario: Chinese grid-forming/BESS commoditization + a permanently sub-scale HBS ⇒ SMA becomes a low-margin regional utility-inverter assembler with no growth premium — plausible over 3–5 years, maybe 30–35% probability.

Lens 14 · Management Questions (ordered by information value)

1. HBS lost €375.6m of EBIT in 2025 — how much of that is permanent competitive impairment vs one-time, and at what revenue level does HBS actually breakeven at cash level?
2. What is your defensible answer to Sungrow/Huawei entering grid-forming and utility BESS — where specifically is your moat non-replicable in 24–36 months?
3. Of the €242m EBIT gap between operating and reported 2025 EBIT, how much recurs in 2026 and 2027? When do "one-time items" actually stop?
4. LSP EBIT margin fell 19.3%→16.6% and you guide lower again for 2026 — where does normalized LSP margin settle through-cycle, and why?
5. How exposed is the ~€1.35bn backlog / ~48%-Americas LSP revenue to a US Chinese-inverter ban that doesn't happen, or to US solar tariff cost-inflation?
6. Q1 2026 operating cash flow was −€22m against improving EBITDA — what is the full-year 2026 cash-conversion and net-cash bridge?
7. Is the €224m cumulative cost-out fully in the run-rate by end-2026, and what's the incremental margin on it if HBS volumes recover?
8. What is the strategic logic of the HyperStrong (Chinese BESS) partnership vs the "non-Chinese supply chain" positioning you sell to US utilities — is that a contradiction?
9. Given the Danfoss ~20% stake and power-electronics ties — is there a scenario (full combination, JV, take-private) on the table, and what governance guardrails protect minorities?
10. Why extend the CEO to 2028 after the 2024 guidance failures, and what has changed in the forecasting/planning process to prevent a repeat?
11. When does the dividend resume, and what capital-return framework governs it given net-cash and no leverage?
12. What share of R&D is now expensed vs capitalized after the 2026 reduction, and is that the new steady-state (quality-of-earnings)?
13. Gigawatt Factory to 40 GW — what utilization/volume assumption underwrites that capex, and what's the impairment risk if European volumes stay depressed?
14. SiC power-semiconductor supply — single-source exposure, pricing, and how it gates the grid-forming roadmap?
15. Three years out, is SMA a growth company (BESS/grid-services) or a cyclical utility-inverter supplier — and how should the market value the mix?

---